Compare Oscar Health Inc (OSCR) vs SiTime Corporation (SITM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs SiTime Corporation — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while SiTime Corporation trades at $612.37 (market cap $19.42B). The key difference: SiTime Corporation is the larger of the two by market cap, and Oscar Health Inc is trading nearer its 52-week high, SiTime Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and SiTime Corporation for 18 Days on average.
| OSCR | SITM | |
|---|---|---|
Market Cap | $10.22B | $19.42B |
Volume | 4,123,394 | 360,307 |
Sector | Health | Technology |
52-Week High | $33.81 | $901.60 |
52-Week Low | $10.85 | $252.76 |
Typical Hold Time | 15 Days | 18 Days |
Enterprise Value | $6.57B | $18.82B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
SITM trades at $612.37, down 7.94% over 24 hours, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with a 126.5% revenue surge to $157.43M and achieving its first GAAP profit. Analyst consensus is unanimously bullish with a $751.43 price target, citing AI-driven growth and market leadership in MEMS timing solutions.
The outlook is positive, driven by AI infrastructure demand and operational leverage, but risks include high valuation multiples, negative 2025 net income, and insider selling. The stock offers significant upside potential if growth continues, though execution and market volatility pose challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About SiTime Corporation
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →
